Yolia Health

medical devices

About

If you're over 39 years and experiencing blurred vision when reading or doing other close work, you are probably suffering from presbyopia; an age-related condition that affects more than 135 million people in the United States. Yolia developed the 1st safe, non-invasive and repeatable treatment for presbyopia. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses and specially formulated eye drops – which, when used together leads to superior vision. After only 3-5 days of treatment with TVT patients are able to stop using the TVT contact lenses, TVT eye drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia's TVT improves both near and distance vision, a unique feature no single other alternative can provide.

Technologies

DNSimple Gmail Google Apps GoDaddy Hosting Android IoT AI Remote

Keywords

noninvasive vision restoration presbyopia correction specialty contact lenses ophthalmology optometry biotechnology medical devices life sciences eyewear consumer goods medical consumers health care non-invasive presbyopia solution customized eye care self-administered eye therapy vision correction solution home-based treatment patient care non-invasive therapy corneal modification vision improvement eye drops formulation refractive correction device vision correction at home vision correction device vision correction for active adults eye drops for vision safe vision correction vision correction

Location

3210 Merryfield Row, San Diego, California, United States, 92121

Related Companies

Companies in the same industry